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Abstract  
 
There has been increasing interest in the effect of ultrafine particles (UFP) on 
human cardiovascular and respiratory health. The adverse health impacts due 
to particle exposure are currently attributed to the mass concentration or the 
chemical composition of particles smaller than 10 μm (PM10) or 2.5 μm (PM2.5) 
in diameter. However, it has been hypothesised that it is actually UFP (< 0.1 
μm) measured in terms of number concentration, as opposed to mass 
concentration,  that might be responsible for the observed health effects. This 
paper presents the results of a critical literature review aimed at analysing the 
current state of epidemiological evidence for the effects of UFP on human 
health. In summary, the array of epidemiological studies conducted thus far 
suggests that UFP exposure is associated with human mortality, and respiratory 
and cardiovascular morbidity. This holds true despite the considerable gaps in 
knowledge that remain, and despite the inconsistencies found between some 
studies, resulting from some deficiencies in the study designs. The limited 
number of epidemiological studies conducted thus far indicates that there are 
comparable health effects of fine and ultrafine particles, which appear to be 
independent of each other. Fine particles show more immediate effects whilst 
ultrafine particles show more delayed effects on mortality. However, at present 
the database is too limited (in terms of both number of studies and number of 
subjects) and geographically restricted, to allow clear conclusions on the mode 
of action and/or generalisation to other settings. Consequently, it is 
recommended that further, better-designed studies be initiated to improve the 
understanding of health impacts of UFP. 
 
Keywords:  ultrafine particles, health effects, epidemiological research, 
mortality, morbidity, respiratory, cardiovascular 
 
 
1. Introduction 
 
While an association between ambient particulate 
matter (PM), and respiratory and cardiovascular 
disorders has been long been recognised, it is not 
clear which fraction of PM is responsible for the 
observed health implications. The adverse health 
effects of particle exposure are currently attributed 
to the mass concentration of particles smaller than 
10 μm (PM10) or 2.5 μm (PM2.5) in diameter, 
although it has been hypothesised that it is ultrafine 
particles (UFP, < 0.1 μm) that might be most toxic 
and thus responsible for the observed health 
effects. Ambient UFP originate primarily from 
combustion sources (e.g. mobile sources such as 
on-road vehicles; and stationary sources such as 
electrostatic precipitators, bag houses etc) (Cass et 
al. 2000). UFP only constitute up to 8% of the mass 
of PM in ambient air, however they are present in 
very high numbers, have much greater surface 
area than larger particles and may be deposited in 
greater numbers in the lungs. Toxicological studies 
also indicate that UFP are more potent in inducing 
cellular damage than larger particles and can 
access circulatory system and move from lungs to 
other organs more easily (Morawska et al. 2004). 
The aim of this study was to review the state of 
epidemiological evidence for the health impacts of 
UFP. This research was restricted to the studies 
reported in peer-reviewed literature, and those that 
directly investigated ambient UFP or their specific 
fractions, or those that linked health effects to 
complex mixtures of pollutants were excluded. The 
authors are of the opinion that even if UFP were 
important components of such mixtures, the 
absence of good characterisation and quantification 
of the composition of all fractions of ambient PM 
means that the effects from UFP cannot be 
decoupled from the effects of other components of 
PM. 
 
2. Epidemiological Evidence of UFP 
Impacts on Human Health  
 
2.1. Overview of Studies and Summary of 
Main Findings 
 
A number of epidemiological studies have 
addressed the association between ambient UFP 
concentrations and the mortality/morbidity of urban 
populations, however this number is relatively 
small. Thus far, only thirteen epidemiological 
studies have reported on respiratory and 
cardiovascular mortality or morbidity due to 
exposure to UFP: one study (Wichmann et al. 
2000) – reported on both respiratory and 
cardiovascular mortality; seven studies (Osunsanya 
et al. 2001, Pekkanen et al. 1997, Penttinen 2001, 
Peters et al. 1997, Timonen et al. 2004, Tiittanen et 
al. 1999, von Klot et al, 2002) – reported on 
respiratory morbidity; and five studies (de Hartog et 
al. 2003, Pekkanen et al. 2002, Ruckerl et al. 2006, 
Vinzents et al. 2005, Henneberger et al. 2005) – 
reported on cardiovascular morbidity. The vast 
majority of these studies were conducted within the 
framework of the European “Exposure and risk 
assessment for fine and ultrafine particles in 
ambient air” (ULTRA) program, by the same teams 
of researchers from Finland, Germany and the 
Netherlands. Noteworthy, the same datasets for the 
particle concentrations were used in several 
studies for the investigation of different health 
outcomes.  
 
2.1.1. Study designs 
 
The studies were limited to the investigation of the 
acute health effects of short-term exposures, which 
evaluated the impact of day-to-day variation in 
ambient pollution on health. These studies have 
correlated morbidity and mortality with daily 
pollution levels. The general approach was to 
compare the health effects associated with various 
fractions of PM. Study outcomes ranged from 
mortality counts of populations to changes in 
specific parameters or biomarkers in individuals. 
While the results of all studies except Vinzents 
et al. (2005) were described as providing exposure-
response relationships, the measurements were 
conducted at single, fixed-point locations 
representing “urban background” levels and they 
only provided information on ambient 
concentration-response relationships across the 
population studied. Namely, data was collected at 
individual monitoring sites located in mixed-use 
urban areas (residences, offices, schools, hospitals 
etc) close to the centre of the cities and 
approximately 40-50 m away from the major roads. 
The main sources of air pollution at these locations 
were traffic and domestic heating, as well as the 
power plants (in Erfurt and Kuopio). Particle 
number concentrations in different size classes 
were measured with the mobile aerosol 
spectrometers and condensation particle counters 
were used to measure the total number 
concentration of particles with a lower detection 
limit of 0.007 μm. PM2.5 were measured with 
Harvard impactors and PM10 were measured with 
TEOM. Elemental carbon (EC) and organic carbon 
(OC) were determined from the ambient carbon 
monitors. Confounding factors (data on gaseous 
pollutants and meteorological variables of 
temperature, barometric pressure, relative humidity 
and wind speed) were collected from existing 
networks. 
Unlike other investigations, the study by 
Vinzents et al. (2005), conducted in Denmark, 
assessed the relationship between time-resolved 
personal exposure to both traffic- and indoor-
related number concentrations of UFP and 
oxidative DNA damage in mononuclear blood cells. 
Condensation particle counters (TSI 3007; TSI, St. 
Paul, MN, USA) which provided continuous 
measurement of the number concentrations of UFP 
were carried in the backpacks of fifteen healthy 
non-smoking subjects, with the inlet tube placed in 
the breathing zone. This allowed for the study of 
exposure-response relationships associated with 
variations in outdoor exposure for individuals, due 
to differences in traffic density and meteorological 
conditions. 
The following is a summary of the main 
findings of these epidemiological studies with 
respect to the health effects of UFP.  
 
2.1.2. Mortality studies 
 
• A study on daily mortality conducted in 
Germany (Wichmann et al. 2000) showed 
comparable and independent increases in 
mortality in association with ultrafine and fine 
particles.  
• The mortality data suggested that fine particles 
have immediate health effects whereas UFP 
have more delayed effects. The immediate 
effect of exposure was found to be respiratory 
disease mortality whereas the delayed effects 
generally involved an increase in 
cardiovascular disease mortality.  
 
2.1.3. Respiratory morbidity 
 
• Panel morbidity studies with asthmatic subjects 
indicate that both fine and ultrafine particles are 
associated with the respiratory health of the 
exposed population (Peters et al 1997; 
Pekkanen et al. 1997; Tiittanen et al. 1999; von 
Klot et al. 2002). A decrease in respiratory 
functions (e.g. peak expiratory flow) and an 
increase in symptoms and medication use were 
associated with elevated particle 
concentrations of UFP, independently from fine 
particles.  
• There is an indication that the acute effects of 
UFP number on respiratory health are stronger 
than that of the mass of fine particles 
(Penttinen 2001). 
• The acute effects of UFP on respiratory health 
of adult asthmatics are more profound than for 
children with asthma symptoms (Pekkanen et 
al. 1997; Tiittanen et al. 1999). 
• Inflammatory events in the lungs take several 
days to develop (von Klot et al, 2002). It is likely 
that a lag time exists between exposure to UFP 
and the acute respiratory health effects of the 
exposed population. Cumulative effects over 5 
days seem to be stronger than same day 
effects (Peters et al. 1997). 
 
2.1.4. Cardiovascular morbidity 
 
• There is association between exposure to UFP 
and cardiovascular morbidity in a population 
with chronic heart disease. Panel studies 
among subjects with coronary heart disease 
indicate that there are independent 
associations between both fine and ultrafine 
particles and the risk of ST-segment 
depression, which is used as indicator of 
myocardial ischemia, in the exposed population 
(Pekkanen et al. 2002).  
• There is an indication that the effect of both fine 
and ultrafine particles on cardiovascular 
morbidity is at least partly mediated through 
increased susceptibility to myocardial 
ischaemia (Pekkanen et al. 2002). 
• The results also suggest that inflammation, as 
well as parts of the coagulation pathway, may 
contribute to the association between 
particulate air pollution and coronary events 
(Ruckerl et al. 2006). 
• Elevated concentration of UFP may have a 
significant immediate effect on physiological 
measures of cardiovascular functions, such as 
QTc duration, T-wave complexity and T-wave 
amplitude (Henneberger et al. 2005). These 
results provide evidence for a deleterious effect 
of UFP on myocardial substrates and 
vulnerability, key factors in the mechanisms of 
cardiac death. 
• Oxidative DNA damage to base pairs in 
circulating mononuclear blood cells is 
associated with personal exposure to UFP and 
short-term higher intensity exposure in traffic is 
associated with elevated levels of damage 
(Vinzents et al. 2005). These results indicate 
that biologic effects of UFP occur at modest 
exposures, such as those occurring in traffic, 
which supports the relationship between UFP 
and the adverse health effects of air pollution. 
These results reinforce the important role of 
UFP in causing oxidative stress. Moreover, 
concern about the health effects of small high-
intensity exposures of UFP in ambient air may 
also be relevant. 
 
Figure 1 (in Appendix) presents the odds ratios and 
95% confidence intervals reported in the morbidity 
studies. It can be seen that the odds ratios were 
typically greater than or close to 1.00, which 
suggests some increased risk, while the 95% 
confidence intervals indicate that these increases 
do not reach statistical significance since, in 
general, they include 1.00 within their ranges. 
 
2.2. Uncertainties in the Epidemiological 
Evidence of the Health Impacts of UFP 
 
Although the vast majority of studies observed 
pathologic effects associated with UFP, which were 
independent of fine particles, some results suggest 
that the effects of larger particles, especially of 
accumulation mode particles (with the diameters 
between 0.1 and 1 μm), may be stronger than the 
effects of UFP. On the other hand, there are a few 
reports that suggest an opposite tendency.  
Analysis of the concentration levels measured 
in the morbidity studies revealed that, although the 
studies demonstrated the highly variable size and 
number distribution, as well as chemical 
composition of particles, the mean concentrations 
of UFP were comparable in all centres. The number 
concentration trends of UFP did not follow the 
trends of either PM10 or PM2.5 concentrations, while 
particle mass concentrations were typically inter-
correlated within the studies. The mean number 
concentration of UFP across the centres typically 
ranged from 1.00 x 104  to 2.10 x 104 particles/m3, 
with the overall mean value of 1.56 ± 8.56 x 10 
particles/m3. 
As the UFP concentrations were comparable in 
all studies, levels of exposure cannot be used to 
explain the different health outcomes. The 
inconsistencies found between studies may be due 
to the study designs. Specifically, all these results 
were based on the particle concentrations 
measured at a single monitoring site, which may 
not be a good proxy measure for the personal 
exposure of subjects. While the results of the 
studies were described as providing exposure-
response relationships, they actually provided 
information on ambient concentration-response 
relationships across the population studied. 
However, it is unlikely that the measurements taken 
at a single monitoring site will give a reasonable 
estimate of overall outdoor pollutant exposure. 
Thus, it is not clear what impact this had on the 
observed (or unobserved) associations between 
UFP and daily morbidity, and whether the results 
were due to biases in the measurement of 
exposure to UFP caused by the monitoring ambient 
levels of air pollutants at a single sites rather than 
measuring total exposure of each member of the 
study population. To quantify the associated risks 
and health impacts of UFP, it is necessary to obtain 
a description of the full-range of exposure 
distribution. To achieve these goals, measurements 
should be taken at multiple outdoor locations, to 
gain a better representation of the UFP exposures 
of large, spatially dispersed populations.  
 
2.3. Sensitive Exposure Groups 
 
So far, no systematic attempts have been reported 
to identify and define sensitive exposure groups 
with regard to UFP. It is, therefore, assumed that 
the subpopulations that have been considered 
more susceptible to the effects of air pollutants 
containing particulate matter in general will also be 
more susceptible to the effects of UFP. Thus, the 
subpopulations that are likely to be at greatest risk 
due to exposure to ambient UFP may include:  
• Individuals with respiratory disease (e.g. COPD, 
acute bronchitis, and asthma) and/or 
cardiovascular disease (e.g. ischemic heart 
disease); 
• Individuals with infectious respiratory disease 
(e.g. pneumonia) (exposure to UFP might also 
increase individual susceptibility to respiratory 
infections); 
• Elderly individuals; and 
• Children. 
 
2.4 Monitoring Particle Number or Particle 
Mass Concentrations 
 
While toxicological studies demonstrate that the 
primary determinant of the effect of UFP is their 
number and their surface area, the available data 
provides only modest epidemiological support for 
the hypothesis that it is the number concentration of 
UFP, rather than the mass concentration, that is 
important in driving the health effects. 
Nevertheless, given the UFP relevance to human 
heath, it is not sufficient to only study associations 
between health outcomes based on the mass of 
particles e.g. PM10 and PM2.5. This is best 
illustrated by developments in Erfurt over a seven 
year period. While the mass of PM2.5 was shown to 
reduce from 1991 to 1998, the number 
concentration of UFP was stable and the smallest 
size fraction of UFP (particles between 0.01 and 
0.03 μm diameter) increased steadily over the 
seven years of observation. These trends clearly 
demonstrate that the reduction of PM2.5 does not 
automatically mean that the number of UFP is also 
reduced. Thus, PM2.5 cannot be used as indicator 
for UFP. Identification of the relevant particle 
fraction with respect to human health is, therefore, 
crucial for sound regulatory activities.  
 
 
 
 
2.5. Conclusions 
 
Despite the limited array of epidemiological studies 
conducted thus far, the current state of knowledge 
on the health effects of UFP does suggest that UFP 
exposure is associated with respiratory and 
cardiovascular effects, and that there are 
comparable health effects of fine and ultrafine 
particles, which appear to be independent of each 
other. This holds true despite considerable gaps in 
knowledge and some inconsistencies that were 
found between studies. Fine particles tend to show 
more immediate effects while UFP show more 
delayed effects on mortality. Therefore, such 
results or outcomes could serve as pointers for 
future investigations or formulations of hypotheses, 
but not as scientifically justifiable conclusions. 
Given that there is a poor correlation between 
UFP (measured by number) and fine particle mass, 
observed statistical independence (in the multiple 
regression models) is of significance. Furthermore, 
given that fine and ultrafine particles often originate 
from common sources, given the dynamics of 
particle formation and accumulation, and given the 
different observed lead-lag relationships between 
exposure and observed health responses, it is 
currently difficult to make very strong inferences 
about independent effects, based on the 
epidemiological evidence provided so far. Further 
better-targeted studies in other settings should be 
initiated to improve the understanding of UFP and 
health outcomes.  
 
3.  Recommendations for Future 
Epidemiological Studies to Address 
Gaps in Knowledge of Health Effects 
of UFP  
 
Knowledge gained from the epidemiological studies 
reported to date has improved scientific 
understanding of the impacts of UFP on human 
health, compared to a few years ago. Nevertheless, 
further, better-designed studies will provide much 
clearer answers on the health implications of UFP. 
The design of such studies can now target the 
specifics of UFP (e.g. characteristics and dynamics 
of UFP in atmospheric systems) which differ from 
other size fractions and characteristics of ambient 
PM. The World Health Organization “Guidelines for 
concentration and exposure-response 
measurement of fine and ultrafine particulate matter 
for use in epidemiological studies” (WHO 2002) is 
an example of the progress in understanding how 
UFP specifics should be dealt with in study designs 
with respect to facilitating the usefulness of data. 
The following are the specific recommendations for 
future epidemiological studies regarding to health 
implications of UFP: 
1. To quantify the associated risks and health 
impacts of UFP, it is necessary to obtain a 
description of the full-range of exposure 
distribution. Thus, air monitoring should be 
conducted at multiple outdoor locations, over 
various distances from the sources of UFP, 
rather than at a single, centrally located 
monitoring site, for a better representation of 
the UFP exposures of large, spatially dispersed 
populations. 
2. Study designs and statistical approaches used 
should allow for the decoupling of the effects of 
UFP from those of other particle size modes. 
3. Studies should be conducted over longer 
periods of observation, to enable comparison of 
effects during periods with high UFP exposure 
and periods likely to have low exposures. 
Longer periods of observation would also 
enable an evaluation of the lag phase between 
exposure and effect.  
4. Studies should be conducted with larger 
sample sizes to enable better modelling of the 
role of diverse demographic and clinical 
variables in the effect of UFP. In addition, 
studies should specifically target potentially 
susceptible subgroups and provide information 
on the susceptibility of particular groups of the 
population. 
5. Taking note of the reported differences in UFP 
concentrations and other characteristics 
between different geographical locations 
(resulting from the differences in the local 
sources, their strength and characteristics, 
meteorology, topography etc), as well as the 
differences in demographic, socio-economic 
and urban use factors, it is expected that the 
type and the magnitude of the responses will 
differ between different locations. It is therefore 
recommended that future studies be conducted 
in selected places in Australia to quantify the 
relationship between exposure to UFP and 
health outcomes in an Australian setting. The 
outcomes of such studies would provide 
appropriate guidance to the decision makers on 
the most desirable steps in controlling 
exposure to UFP in Australia. 
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Chest pain upon physical exertion, 5-day Mean [5]
Chest pain upon physical exertion, Same day [5]
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Cough, 5-day Mean [1]
Cough, 5-day Mean [4]
Cough, Same day [1]
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Cough, Same day [3]
Cough, Same day [4]
CRP plasma concentration, 5-day Mean [7]
CRP plasma concentration, Same day [7]
ICAM-1 plasma concentration, 5-day Mean [7]
ICAM-1 plasma concentration, Same day [7]
Medication use, 5-day mean [4]
Medication use, Same day [4]
Phlegm, 5-day Mean [5]
Phlegm, Same day [5]
Shortness of breath, 5-day Mean [4]
Shortness of breath, 5-day Mean [5]
Shortness of breath, Same day [4]
Shortness of breath, Same day [5]
ST-segment depression [6]
Waking up with breathing problems, 5-day Mean [4]
Waking up with breathing problems, 5-day Mean [5]
Waking up with breathing problems, Same day [4]
Wheezing, 5-day mean [4]
Wheezing, Same day [4]
 
 
Fig.1. Summary of the results of the morbidity studies on the association of UFP with health outcomes: odds 
ratios (dots) and 95% confidence interval (bars) for ultrafine particles by study. [1] - Peters et al., 1997; [2] - 
Tiittanen et al, 1999; [3] - Osunsanya et al. 2001; [4] - von Klot et al 2002; [5] - de Hartog et al., 2003; [6] - 
Pekkanen et al., 2002; [7] - Ruckerl et al., 2006. 
 
 
